e-learning
resources
ERJ
2001
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Trials of inhaled Iloprost and other new vasodilating prostaglandins
Higenbottam T., Siddons T.
Source:
Eur Respir J 2001; 17: 6-7
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Higenbottam T., Siddons T.. Trials of inhaled Iloprost and other new vasodilating prostaglandins. Eur Respir J 2001; 17: 6-7
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 1037-1049
Year: 2002
Late-breaking abstract: Urinary leukotriene E
4
/exhaled nitric oxide ratio as a predictor of exercise-induced bronchoconstriction control by oral montelukast or inhaled corticosteroid
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002
Protective effect of inhaled iloprost on exercise-induced bronchoconstriction
Source: Eur Respir J 2004; 24: Suppl. 48, 443s
Year: 2004
Comparative effects of inhaled nitric oxide and aerosolized iloprost during vasoreactivity testing in chronic pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 561s
Year: 2005
Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
Differential action of beraprost isomers on prostacyclin (IP) receptors and PPARβ in pulmonary arteries
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Combination of inhaled nitric oxide and an endothelin
A
-receptor antagonist in acute pulmonary thromboembolism
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Emerging inhaled bronchodilators: an update
Source: Eur Respir J 2009; 34: 757
Year: 2009
Anti-inflammatory effects of histamine H
1
-receptor antagonist and leukotriene CysLT
1
-receptor antagonist in patients with atopic asthma maintained on inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 221s
Year: 2004
Abediterol has higher bronchodilatory potency and reduced cardiac effects versus other long-acting beta
2
-agonists in dogs
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
The vasodilator response to inhaled nitric oxide (iNO) predicts the short term evolution with oral vasodilators in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006 Oct 01;28(4):691-694
Year: 2006
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004
Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
Source: Eur Respir J 2002; 20: 339-343
Year: 2002
Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Inhaled iloprost for the treatment of pulmonary hypertension
Source: Eur Respir Rev 2009; 18: 29-34
Year: 2009
PDE 3/4 inhibition prolonges pulmonary vasodilatory response to inhaled iloprost
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept